SCHEMBL8068305

SCHEMBL8068305

O=[C]On1ccccc1=S

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ MMP3 P08254 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ TBXA2R P21731 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ LOX P28300 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ LOXL3 P58215 1/20 0.40
▸ LOXL4 Q96JB6 1/20 0.40
▸ LOXL2 Q9Y4K0 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CA3 P07451 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8068307 0.72 ESR1 (0.41) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL13341452 0.71 — —
SCHEMBL18883779 0.71 — —
SCHEMBL9142955 0.68 — —
SCHEMBL13019256 0.68 ESR1 (0.42) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL19661200 0.68 ESR1 (0.42) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL18116995 0.67 ESR1 (0.41) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL18116993 0.67 ESR1 (0.41) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL18116997 0.67 ESR1 (0.41) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL18116961 0.67 ESR1 (0.41) ESR1HSP90AA1MMP3CHRM1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0883628-B1 17BETA-(2-OXO-TETRAHYDROFURAN-4-YL)-THIO-ANDROSTANE DERIVATIVES (17BETA-(GAMMA-BUTYRIC ACID LACTONE)-THIO DERIVATIVES) FOR THE TREATMENT OF INFLAMMATION AND PHARMACEUTICAL COMPOSITIONS AND A PROCESS FOR THE PRODUCTION THEREOF GLAXO GROUP LTD (GB) 2000-08-16 — — EP claimed
EP-0883628-A1 17BETA-(2-OXO-TETRAHYDROFURAN-4-YL)-THIO-ANDROSTANE DERIVATIVES (17BETA-(GAMMA-BUTYRIC ACID LACTONE)-THIO DERIVATIVES) FOR THE TREATMENT OF INFLAMMATION AND PHARMACEUTICAL COMPOSITIONS AND A PROCESS FOR THE PRODUCTION THEREOF GLAXO GROUP LIMITED (GB) 1998-12-16 — — EP claimed
US-5801165-A Antiinflammatory, immunosuppressive and antialleric 16, 17-alkylidioxy-steroids RHONE-POULENC RORER LIMITED (GB) 1998-09-01 — — US claimed
WO-1997024368-A1 17BETA-(2-OXO-TETRAHYDROFURAN-4-YL)-THIO-ANDROSTANE DERIVATIVES (17BETA-(GAMMA-BUTYRIC ACID LACTONE)-THIO DERIVATIVES) FOR THE TREATMENT OF INFLAMMATION AND PHARMACEUTICAL COMPOSITIONS AND A PROCESS FOR THE PRODUCTION THEREOF GLAXO GROUP LIMITED (GB) 1997-07-10 — — WO claimed
EP-0675897-B1 NEW STEROIDS RHONE POULENC RORER LTD (GB) 1997-06-18 — — EP claimed
EP-0675897-A1 NEW STEROIDS. RHONE POULENC RORER LTD (GB) 1995-10-11 — — EP claimed
WO-1994014834-A1 NEW STEROIDS RHONE-POULENC RORER LIMITED (GB) 1994-07-07 — — WO claimed
US-6114318-A ANTIINFLAMMATORY AGENT, ANTIALLERGENS GLAXO GROUP LIMITED (GB) 2000-09-05 — — US disclosed
EP-0883628-B1 17BETA-(2-OXO-TETRAHYDROFURAN-4-YL)-THIO-ANDROSTANE DERIVATIVES (17BETA-(GAMMA-BUTYRIC ACID LACTONE)-THIO DERIVATIVES) FOR THE TREATMENT OF INFLAMMATION AND PHARMACEUTICAL COMPOSITIONS AND A PROCESS FOR THE PRODUCTION THEREOF GLAXO GROUP LTD (GB) 2000-08-16 — — EP disclosed
US-5801165-A Antiinflammatory, immunosuppressive and antialleric 16, 17-alkylidioxy-steroids RHONE-POULENC RORER LIMITED (GB) 1998-09-01 — — US disclosed
EP-0675897-B1 NEW STEROIDS RHONE POULENC RORER LTD (GB) 1997-06-18 — — EP disclosed
EP-0675897-A1 NEW STEROIDS. RHONE POULENC RORER LTD (GB) 1995-10-11 — — EP disclosed
US-5453502-A 1,3,4 substituted and bicyclic derivatives of 2-azetidinones and processes for preparation thereof ELI LILLY AND COMPANY (US) 1995-09-26 — — US disclosed
EP-0672656-A1 1,3,4 substituted and bicyclic derivatives of 2-azetidinones and processes for preparation thereof ELI LILLY AND COMPANY (US) 1995-09-20 — — EP disclosed
WO-1994014834-A1 NEW STEROIDS RHONE-POULENC RORER LIMITED (GB) 1994-07-07 — — WO disclosed
US-5037975-A Antibiotics ELI LILLY AND COMPANY (US) 1991-08-06 — — US disclosed
US-4939249-A HEATING CEPHALOSPORIN 1,1-DIOXIDE IN SOLVENT WITH FREE RADICAL INITIATOR ELI LILLY AND COMPANY (US) 1990-07-03 — — US disclosed
Send feedback